The MYH2 gene gives skeletal muscles instructions for a protein used mainly in fast type 2A muscle fibers, which help with quick, controlled movements. This gene plays an important role in how your body moves the eyes, limbs, and other muscles during everyday activities. If the MYH2 gene does not work properly, some people develop a muscle condition with weakness, reduced exercise stamina, and limited eye movements. Depending on the variant, joint stiffness from birth or a gradual loss of muscle strength can also occur.
What is a gene?
Genes are stretches of DNA that provide instructions cells use to make molecules or direct activities in the body. Some genes carry the information needed to make proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
MYH2Gene function
What if the gene works
The MYH2 gene helps make a myosin protein used in fast skeletal muscle fibers. This protein lets muscles shorten and generate force for movements such as walking, lifting, and quick changes in pace.
Risk
What if the gene does not work
Variants in the MYH2 gene can cause a muscle condition with weakness and limited eye movements. Effects range from mild adult onset weakness to earlier, more widespread muscle involvement, depending on how much the gene's function is reduced.
Treatment
What does that mean for your treatment
No MYH2-specific treatment or drug selection approach is currently established for people with pathogenic variants in the MYH2 gene. Current research mainly uses the MYH2 gene to better understand muscle disease biology rather than to guide an approved targeted therapy.
Conditions associated with MYH2
Gene function
What if the gene works
Every time you rise from a chair, climb stairs, or lift a bag, certain muscles need quick, controlled force. The MYH2 gene helps make a motor protein used in fast skeletal muscle fibers. Its usual job is to turn stored cell energy into the pull that lets those fibers shorten and move your body.
In fast skeletal muscle fibers, the MYH2 gene provides instructions for part of the motor protein that creates force. This protein repeatedly pulls on actin, the track inside muscle cells, so the fibers shorten and make movement.
Its protein uses ATP, the cell's energy source, to power each pulling step. This is central to how muscles contract during actions like rising from a chair, climbing stairs, or carrying groceries.
MYH2 is especially active in type 2A muscle fibers, which support brisk movements that can be repeated without being all-out effort. That helps muscles combine speed with some staying power during everyday activity.
What is a variant?
In genetics, a variant is a small change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can more substantially change how a gene functions and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MYH2 gene can change the shape of the muscle protein it makes, so it may bind less well to actin (a muscle fiber protein), make less force, or assemble poorly inside the cell. This is how MYH2 gene variants affect muscle protein function: milder variants may leave some activity, while more severe variants can sharply reduce or remove the protein. This range often influences how early MYH2-related muscle weakness appears and how noticeable it becomes.
How variants are linked to conditions
Pathogenic variants in the MYH2 gene cause MYH2-related myopathy, so MYH2 gene variants linked to muscle conditions are a well-established finding in medical genetics. This condition often involves weakness affecting the eyes, face, shoulders, hips, or legs. Some people develop drooping eyelids or limited eye movements, while others notice slowly progressive limb weakness. Both dominant and recessive MYH2 variants have been reported, and the age of onset can vary.
A variant is not necessarily a diagnosis
Variants in genes are a normal feature of human biology and are widely found in the general population. Most of these variants do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a part. In some situations, though, one well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that increase or reduce the chance of a MYH2-related condition. For many living with MYH2 changes, risk is mainly shaped by whether a disease-causing variant is present in the family.
Inheritance of MYH2 variants
The inheritance pattern for MYH2-related conditions can differ depending on the specific variant and condition involved. In many families, variants in the MYH2 gene are inherited in an autosomal dominant way, which means a parent carrying the variant has a 50% chance of passing it to each child. Other MYH2-related conditions follow an autosomal recessive pattern, so a child would need to inherit one variant from each parent. When people look up how MYH2 gene variants are inherited, the key point is that the family pattern depends on the exact MYH2-related diagnosis.
What does my MYH2 result mean for my family?
MYH2-related muscle conditions can run in families in more than one way. In some families, a changed MYH2 result can be passed from an affected parent to a child, so close relatives such as parents, siblings, and children may also carry it. In other families, relatives may be healthy carriers, and brothers or sisters can sometimes be affected even when parents are not. What this means for your family depends on the exact MYH2 result and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
To find out about variants, genetic testing for the MYH2 gene reads DNA from a blood or saliva sample. A lab checks the gene’s sequence for changes and classifies them using current medical evidence. Results may show a benign variant, a pathogenic variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the MYH2 gene may be worth considering if there is unexplained muscle weakness, trouble climbing stairs or lifting the arms, limited eye movements, or a family history of a similar muscle condition. It can help clarify whether MYH2-related muscle disease is the cause.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and the type of variant involved. Over time, the way the body works is also shaped by factors such as age, environment, lifestyle, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other aspects of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment and have different results because their bodies may break down, transport, or respond to a drug in different ways. These inherited differences are common and can influence how well a medication works or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies links between genes and drugs to better explain why the same treatment may work differently from one person to another. For many medicines, genes help determine how strongly a drug works or how the body processes it. This information can support more informed, individualized treatment decisions. To explore this subject in more detail, you can learn more in the LearnHub.
Drugs influenced by the MYH2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. Any concerns about your health, new symptoms, or how you respond to a medicine are best discussed with your doctor.